9 13

Cited 0 times in

What influences aromatase inhibitor continuation intention among breast cancer survivors?

Authors
 Young Kyung Seo  ;  Jeongok Park  ;  Jin-Hee Park  ;  Sue Kim 
Citation
 Korean Journal of Women Health Nursing (여성건강간호학회지), Vol.27(1) : 49-57, 2021-03 
Journal Title
 Korean Journal of Women Health Nursing (여성건강간호학회지) 
ISSN
 1225-9543 
Issue Date
2021-03
Keywords
Aromatase inhibitor ; Breast cancer ; Medication adherence ; Musculoskeletal pain
Abstract
Purpose: Aromatase inhibitors (AIs) are widely prescribed for postmenopausal women with breast cancer and are known to cause musculoskeletal pain. This study aimed to identify factors associated with AI continuation intention among breast cancer survivors (BCS). Methods: A cross-sectional survey was conducted on 123 BCS (stages I–III), who had been taking AIs for at least 6 weeks. Participants were recruited from a cancer center in Goyang, Korea, from September to November 2019. Descriptive statistics, Welch analysis of variance, Pearson correlation coefficients, and simple linear regression were used for the analysis. Results: Beliefs about endocrine therapy was a significant predictor of AI continuation intention (β=.66, p<.001). The majority of participants (87.0%) reported experiencing musculoskeletal pain since taking AIs and the score for the worst pain severity within 24 hours was 5.08±2.80 out of 10. Musculoskeletal pain, however, was not associated with AI continuation intention. Fear of cancer re currence (FCR) was clinically significant (≥13) for 74.0% of the respondents (mean, 17.62±7.14). Musculoskeletal pain severity and pain interference were significantly associated with FCR (r=.21, p<.05; r=.35, p<.01, respectively). Pain interference was significantly associated with beliefs about endocrine therapy (r=–.18, p<.05). Conclusion: AI continuation intention can be modified by reinforcing patients’ beliefs about endo crine therapy. Musculoskeletal pain may have a negative effect on beliefs about endocrine therapy and increase FCR among BCS. Thus, awareness of musculoskeletal pain during AI therapy should be raised and further research is required to develop multidisciplinary pain management strategies and clinical guidelines to reinforce beliefs about endocrine therapy.
Files in This Item:
T202101116.pdf Download
DOI
10.4069/kjwhn.2021.01.19
Appears in Collections:
3. College of Nursing (간호대학) > Dept. of Nursing (간호학과) > 1. Journal Papers
Yonsei Authors
Kim, Sue(김수) ORCID logo https://orcid.org/0000-0003-3785-2445
Park, Jeongok(박정옥) ORCID logo https://orcid.org/0000-0003-4978-817X
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/182391
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links